ADAnna Yur'EVna Denisova

Anna Yur'EVna Denisova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Yur'EVna Denisova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ASSOCIATION BETWEEN ACUTE KIDNEY INJURY AND IN-HOSPITAL MORTALITY IN PATIENTS WITH MYOCARDIAL INFARCTION AND COVID-19

    by Anna Yur′Evna Denisova, Maksim Vital′Evich Menzorov, Sabina Faigovna Kerimova, Viktor Maksimovich Menzorov, Elena Sergeevna Salimzyanova

    Objective. The aim of the paper is to evaluate the incidence and clinical phenotypes of acute kidney injury (AKI) in patients with myocardial infarction (MI) and COVID-19 following percutaneous coronary intervention (PCI), and to assess the association of AKI and its phenotypes with in-hospital mortality. Materials and Methods. We evaluated 132 patients (82 (62 %) men, 50 (38 %) women; median age 68 (62; 74) years) with MI and confirmed COVID-19 who underwent PCI. Results. AKI was diagnosed in 58 (44 %) patients. The distribution by severity stages was as follows: Stage 1 in 45 (77 %) patients, Stage 2 in 8 (14 %), and Stage 3 in 5 (9 %). The community-acquired phenotype predominated (40 (69 %) patients), while hospital-acquired AKI was observed in 31 % of cases (18 patients). In 21 (36 %) patients, AKI superimposed on pre-existing chronic kidney disease (CKD), whereas the remaining 37 (64 %) patients had no prior history of CKD. AKI was present in the majority of patients who died in the hospital (19 (76 %)), and its presence was associated with a significantly increased risk of in-hospital mortality (OR 5.52; 95 % CI 2.01–15.13; p=0.0008). In-hospital mortality was highest in patients with community-acquired new-onset AKI and those with hospital-acquired AKI superimposed on CKD (10 (38 %) and 5 (56 %) patients, respectively). Conclusion. Patients with MI and COVID-19 undergoing PCI exhibited a high incidence of AKI, predominantly characterized by Stage 1 severity and the community-acquired new-onset phenotype. AKI was associated with a significantly increased risk of in-hospital mortality. The most unfavorable phenotypes regarding in-hospital death were community-acquired new-onset AKI and hospital-acquired AKI superimposed on CKD.

  • ACUTE KIDNEY INJURY IN PATIENTS WITH MYOCARDIAL INFARCTION AND NEW CORONAVIRUS INFECTION (COVID-19)

    by Anna Yur'EVna Denisova, Maksim Vital'EVich Menzorov, Sabina Faigovna Kerimova, Maksim Vasil'EVich Gorbunov, Viktor Maksimovich Menzorov, Emma Olegovna Bubas

    Acute kidney injury is a common pathological condition that complicates various diseases and affects both the short-term and long-term prognosis. There is ample research which testifies the unfavorable prognostic role of acute kidney injury in patients with myocardial infarction. The problem of acute kidney injury has become especially relevant during the COVID-19 pandemic, periodic outbreaks of which associated with new virus mutation are still observed. COVID-19 can both destabilize the existing pathology and lead to the development of new diseases, including myocardial infarction. In patients with myocardial infarction and COVID-19, a multiplicative risk effect of getting acute kidney injury is expected, the mechanism of which is likely to be different in each particular case: COVID-19 can simultaneously lead to a combination of renal and cardiac complications; acute kidney injury can develop due to heart failure, direct heart injury or myocardial infarction regardless of the new coronavirus infection. The article reviews the studies on the correlation between creatinine levels, renal dysfunction and the risk of myocardial infarction in COVID-19 patients. The authors describe the pathophysiological basis of cardiorenal correlation in COVID-19, which is characterized by the complexity and uniqueness of changes.

  • Open Access

    The concept of acute kidney disease and its place in the renal continuum

    by Vladimir S. Sakharov, Maksim V. Menzorov, Anna Y. Denisova, Sabina F. Kerimova, Valentina V. Matyushina

    The paper discusses the concept of acute kidney disease, a relatively new concept in clinical medicine, the introduction of which is due to the presence of kidney diseases that do not meet strict criteria for acute kidney injury or chronic kidney disease. The article presents the criteria and severity stratification of acute kidney disease proposed by the Kidney Disease: Improving Global Outcomes Foundation, interpretation of the criteria and severity stratification by the Scientific Society of Nephrologists of Russia, associations of nephrologists and anesthesiologists-resuscitators of Russia, the National Society of Specialists in Hemapheresis and Extracorporeal Hemocorrection in accordance with the classification system of the Acute Dialysis Quality Initiative group. The role of acute kidney disease in the modern renal continuum is outlined. The article reviews the results of studies of acute kidney disease in patients with septic shock, patients who underwent total joint replacement, myocardial infarction with ST segment elevation and having acute kidney injury, patients with ischemic stroke, after coronary angiography, after acute surgery for type A aortic dissection, which demonstrate the prevalence of acute kidney disease and its outcomes. Despite the fact that acute kidney disease has a high prevalence among patients with various pathologies, worsens the prognosis and increases the risk of death or complications, its significance in modern medicine remains extremely underestimated. The article identifies the most common and studied biochemical markers that can potentially increase the proportion of patients at risk of adverse outcomes when used in clinical practice.


  • ACUTE KIDNEY INJURY IN PATIENTS WITH PULMONARY ARTERY THROMBOEMBOLIA

    by V.V. Filimonova, M.V. Menzorov, A.YU. Bol'SHakova

    The aim of the study is to diagnose acute kidney injury, its severity, and types in patients with pulmonary artery thromboembolia (PATE), to establish the correlation between AKI and the estimated mortality risk, hospital mortality. Materials and Methods. The study enrolled 111 patients (61 males (55 %), and 50 females (45 %), average age 66.8±11.7 years) with PATE, hospitalized to the cardiology department of Ulyanovsk Central City Clinical Hospital. Results. Acute kidney injury was diagnosed in 36 patients with PATE (34 %): among them 24 patients with stage 1 PATE (67 %); 7 patients with stage 2 (19 %); 5 patients with stage 3 (14 %). Prehospital complications were diagnosed in 20 patients (56 %), hospital AKI was detected in 16 patients (44 %). CKD-associated AKI was observed in 24 patients (67 %), de novo AKI was diagnosed in 12 trial subjects (33 %). Twenty-six patients (23 %) died during hospitalization. The relative hospital mortality risk in AKI patients was 5.2 (95 % CI: 2.02–13.39; p<0.001). The estimated risk of 30-day mortality according to the PESI score was higher in AKI patients (120.0 (87.5–158,0) and 90 (87.5-158.0), respectively, p=0.004). Conclusion. Patients with PATE had a high incidence of AKI, which was diagnosed in every 3rd patient. In 67 % of patients, AKI was associated with chronic kidney disease. Patients with prehospital AKI prevailed (56 %). AKI in patients with PATE was associated with increased in-hospital mortality and an estimated 30-day mortality risk. Keywords: acute kidney injury, pulmonary embolism, hospital mortality, estimated mortality risk. Цель исследования. Оценить наличие, степень выраженности и варианты острого повреждения почек (ОПП) у пациентов с тромбоэмболией легочной артерии (ТЭЛА); уточнить связь между ОПП и расчетным риском смерти, госпитальной летальностью. Материалы и методы. Обследовано 111 пациентов (мужчин – 61 (55 %), женщин – 50 (45 %), средний возраст – 66,8±11,7 года) с ТЭЛА, госпитализированных в отделение кардиологии ГУЗ «Центральная городская клиническая больница г. Ульяновска». Результаты. Острое повреждение почек диагностировано у 36 (34 %) пациентов с ТЭЛА, причем у 24 (67 %) из них выявлена 1 стадия, у 7 (19 %) – 2 стадия и у 5 (14 %) – 3 стадия. У 20 (56 %) пациентов диагностирован догоспитальный вариант осложнения, госпитальное ОПП выявлялось в 16 (44 %) случаях. ОПП при ХБП имело место у 24 (67 %) обследованных, ОПП de novo – у 12 (33 %). В период госпитализации умерло 26 (23 %) пациентов. Относительный риск смерти в стационаре у пациентов с ОПП составил 5,2 (95 % ДИ: 2,02–13,39; р<0,001). Расчетный риск 30-дневной смерти по шкале PESI при наличии ОПП был выше, чем при его отсутствии (120,0 (87,5–158,0) и 90 (87,5–158,0) соответственно, p=0,004). Выводы. У пациентов с ТЭЛА наблюдается высокая частота ОПП, оно диагностируется у каждого 3-го пациента. У 67 % пациентов острое повреждение почек развивается на фоне предшествующей хронической болезни почек. Преобладают пациенты с догоспитальным ОПП (56 %). Острое повреждение почек у пациентов с ТЭЛА ассоциировано с увеличением госпитальной летальности и расчетного риска 30-дневной смертности. Ключевые слова: острое повреждение почек, тромбоэмболия легочной артерии, госпитальная летальность, расчетный риск смерти.